切换至 "中华医学电子期刊资源库"

中华损伤与修复杂志(电子版) ›› 2024, Vol. 19 ›› Issue (06) : 541 -545. doi: 10.3877/cma.j.issn.1673-9450.2024.06.016

综述

异体富血小板血浆在创面修复中的临床应用进展
李亚龙1, 王星童1, 申传安1,()   
  1. 1.100039 北京,解放军总医院第四医学中心烧伤整形医学部
  • 收稿日期:2024-05-16 出版日期:2024-12-01
  • 通信作者: 申传安
  • 基金资助:
    国家自然科学基金(82272279、82072169)

Clinical advances in the application of allogeneic platelet-rich plasma in wound healing

Yalong Li1, Xingtong Wang1, Chuan'an Shen,1()   

  1. 1.Senior Department of Burns and Plastic Surgery, the Fourth Medical Center of PLA General Hospital,Beijing 100039,China
  • Received:2024-05-16 Published:2024-12-01
  • Corresponding author: Chuan'an Shen
引用本文:

李亚龙, 王星童, 申传安. 异体富血小板血浆在创面修复中的临床应用进展[J]. 中华损伤与修复杂志(电子版), 2024, 19(06): 541-545.

Yalong Li, Xingtong Wang, Chuan'an Shen. Clinical advances in the application of allogeneic platelet-rich plasma in wound healing[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2024, 19(06): 541-545.

复杂难愈性创面的愈合受多种因素调控,可严重影响患者身心健康,给社会带来经济负担。 因此,寻找创新策略以加速复杂难愈创面的愈合显得尤为重要。 自体富血小板血浆(PRP)对创面愈合的积极影响已得到广泛认可,但其临床应用仍存在诸多限制。 相较之下,异体PRP 作为一种前景广阔的替代方法,为临床治疗提供了新的方向。 本文通过探讨异体PRP 在促进创面修复中的机制,展示其在难愈创面中的临床应用实例,分析异体PRP 的安全性、局限性及其未来的发展方向。

The healing of complex and hard-to-heal wounds is influenced by multiple factors,significantly impacting the patient's physical and mental health as well as social economic burden.Therefore,seeking innovative strategies to accelerate the healing process of these wounds is particularly important.Autologous platelet-rich plasma (PRP) has been widely recognized for its positive effect on wound healing,yet its clinical application is still limited due to various constraints.In contrast, allogeneic PRP, as a promising alternative approach,offers a new direction for clinical treatment.This review explores the mechanism of allogeneic PRP in promoting wound repair, presents clinical application examples in hard-toheal wounds, analyzes the safety and limitations of allogeneic PRP, and envisions its future development prospects.

[1]
Marques R, Lopes M, Ramos P, et al.Prognostic factors for delayed healing of complex wounds in adults:a scoping review[J].Int Wound J,2023,20(7):2869-2886.
[2]
Pecová J,Rohlíková V,Šmoldasová M,et al.Clinical efficacy of hyaluronic acid with iodine in hard-to-heal wounds [ J].Pharmaceutics,2023,15(9):2268.
[3]
OuYang H, Tang Y, Yang F, et al.Platelet-rich plasma for the treatment of diabetic foot ulcer: a systematic review[J].Front Endocrinol (Lausanne),2023,14:1256081.
[4]
Li J, Hu WP, Zhong G.Clinical therapeutic effects of plateletrich plasma in patients with burn wound healing:a protocol for systematic review and meta-analysis[J].Medicine (Baltimore),2021,100(31):e26404.
[5]
Niemann M, Ort M, Lauterbach L, et al.Individual immune cell and cytokine profiles determine platelet-rich plasma composition[J].Arthritis Res Ther,2023,25(1):6.
[6]
Harrison P, Subcommittee on platelet physiology.The use of platelets in regenerative medicine and proposal for a new classification system: guidance from the SSC of the ISTH[J].J Thromb Haemost,2018,16(9):1895-1900.
[7]
Kelly K,Cancelas JA,Szczepiorkowski ZM,et al.Frozen plateletsdevelopment and future directions[J].Transfus Med Rev,2020,34(4):286-293.
[8]
Gupta S, Paliczak A, Delgado D.Evidence-based indications of platelet-rich plasma therapy[J].Expert Rev Hematol,2021,14(1):97-108.
[9]
Solari FA, Krahn D, Swieringa F, et al.Multi-omics approaches to study platelet mechanisms[J].Curr Opin Chem Biol,2023,73:102253.
[10]
Bodnar RJ.Chemokine regulation of angiogenesis during wound healing[J].Adv Wound Care (New Rochelle),2015,4(11):641-650.
[11]
Andia I, Abate M.Platelet-rich plasma: underlying biology and clinical correlates[J].Regen Med,2013,8(5):645-658.
[12]
Collins T,Alexander D,Barkatali B.Platelet-rich plasma: a narrative review[J].EFORT Open Rev,2021,6(4):225-235.
[13]
Melincovici CS,Boşca AB,Şuşman S,et al.Vascular endothelial growth factor (VEGF) -key factor in normal and pathological angiogenesis[J].Rom J Morphol Embryol,2018,59(2):455-467.
[14]
Farooq M, Khan AW, Kim MS, et al.The role of fibroblast growth factor (FGF) signaling in tissue repair and regeneration[J].Cells, 2021,10(11):3242.
[15]
Jain NK, Gulati M.Platelet-rich plasma: a healing virtuoso[J].Blood Res, 2016,51(1):3-5.
[16]
舒海宁.同种异体富血小板血浆对糖尿病大鼠深Ⅱ°烫伤创面愈合的影响[D].南华大学,2018.
[17]
Spanò R, Muraglia A,Todeschi MR,et al.Platelet-rich plasmabased bioactive membrane as a new advanced wound care tool[J].J Tissue Eng Regen Med, 2018,12(1):e82-e96.
[18]
Pietrzak WS, Eppley BL.Platelet-rich plasma: biology and new technology[J].J Craniofac Surg, 2005,16(6):1043-1054.
[19]
Xu P,Wu Y,Zhou L,et al.Platelet-rich plasma accelerates skin wound healing by promoting re-epithelialization [ J].Burns Trauma, 2020,8:tkaa028.
[20]
施琳颖, 李艳辉,许京菁,等.富血小板血浆通过调控AMPK信号通路刺激巨噬细胞向M2 型转化的作用研究[J].中国实验血液学杂志,2023,31(5):1486-1491.
[21]
Papait A,Cancedda R,Mastrogiacomo M,et al.Allogeneic plateletrich plasma affects monocyte differentiation to dendritic cells causing an anti-inflammatory microenvironment, putatively fostering wound healing[J].J Tissue Eng Regen Med,2018,12(1):30-43.
[22]
Lei X, Cheng L, Yang Y, et al.Co-administration of plateletrich plasma and small intestinal submucosa is more beneficial than their individual use in promoting acute skin wound healing[J].Burns Trauma,2021,9:tkab033.
[23]
Werner S,Krieg T,Smola H.Keratinocyte-fibroblast interactions in wound healing[J].J Invest Dermatol,2007,127(5):998-1008.
[24]
Mascré G, Dekoninck S,Drogat B,et al.Distinct contribution of stem and progenitor cells to epidermal maintenance[J].Nature,2012,489(7415):257-262.
[25]
许鹏程, 贺伟峰,程飚.转录组水平探讨人富血小板血浆调控人表皮干细胞促创面再上皮化的机制[J].中华烧伤杂志,2020,36(10):915-922.
[26]
van der Bijl I, Vlig M, Middelkoop E, et al.Allogeneic plateletrich plasma (PRP) is superior to platelets or plasma alone in stimulating fibroblast proliferation and migration, angiogenesis,and chemotaxis as relevant processes for wound healing[J].Transfusion,2019,59(11):3492-3500.
[27]
Xian LJ, Chowdhury SR, Bin Saim A, et al.Concentrationdependent effect of platelet-rich plasma on keratinocyte and fibroblast wound healing[J].Cytotherapy,2015,17(3):293-300.
[28]
刘宸, 章宏伟,徐宁.同种异体富血小板血浆可增强糖尿病大鼠合成创面胶原[J].中国组织工程研究,2014,18(39):6329-6334.
[29]
Cl K, Jeyaraman M, Jeyaraman N, et al.Antimicrobial effects of platelet-rich plasma and platelet-rich fibrin: a scoping review[J].Cureus,2023,15(12):e51360.
[30]
Smith OJ,Wicaksana A,Davidson D,et al.An evaluation of the bacteriostatic effect of platelet-rich plasma[J].Int Wound J,2021,18(4):448-456.
[31]
Çetinkaya RA,Yenilmez E,Petrone P,et al.Platelet-rich plasma as an additional therapeutic option for infected wounds with multidrug resistant bacteria: in vitro antibacterial activity study[J].Eur J Trauma Emerg Surg,2019,45(3):555-565.
[32]
Farghali HA,AbdElKader NA,AbuBakr HO,et al.Antimicrobial action of autologous platelet-rich plasma on MRSA-infected skin wounds in dogs[J].Sci Rep,2019,9(1):12722.
[33]
Leisi S, Farahpour MR.Effectiveness of topical administration of platelet-rich plasma on the healing of methicillin-resistant Staphylococcus aureus-infected full-thickness wound model[J].J Plast Reconstr Aesthet Surg,2023,77:416-429.
[34]
Wilkinson HN,Hardman MJ.Wound healing:cellular mechanisms and pathological outcomes[J].Open Biol,2020,10(9):200223.
[35]
Graves N,Phillips CJ,Harding K.A narrative review of the epidemiology and economics of chronic wounds[J].Br J Dermatol,2022,187(2):141-148.
[36]
中国老年医学学会烧创伤分会.浓缩血小板制品在创面修复中应用的全国专家共识(2020 版)[J].中华烧伤杂志,2020,36(11): 993-1002.
[37]
Tashnizi MA, Alamdari DH, Khayami ME, et al.Treatment of non-healing sternum wound after open-heart surgery with allogenic platelet-rich plasma and fibrin glue-preliminary outcomes[J].Indian J Plast Surg,2013,46(3):538-542.
[38]
Shan GQ, Zhang YN, Ma J, et al.Evaluation of the effects of homologous platelet gel on healing lower extremity wounds in patients with diabetes[J].Int J Low Extrem Wounds,2013,12(1):22-29.
[39]
Liao X, Liang JX, Li SH, et al.Allogeneic platelet-rich plasma therapy as an effective and safe adjuvant method for chronic wounds[J].J Surg Res,2020,246:284-291.
[40]
He M,Guo X,Li T,et al.Comparison of allogeneic platelet-rich plasma with autologous platelet-rich plasma for the treatment of diabetic lower extremity ulcers[J].Cell Transplant,2020,29:963689720931428.
[41]
陈若曦, 李升红,卢金强,等.同种异体富血小板血浆治疗糖尿病慢性创面的疗效观察[J].感染、炎症、修复,2021,22(1):10-15,后插1.
[42]
刘鸿雁, 黄文炼,李竺憬,等.同种异体富血小板对糖尿病足创面的愈合再生情况分析[J].中国输血杂志,2021,34(4):358-361.
[43]
刘鸿雁, 黄文炼,李竺憬,等.同种异体富血小板血浆凝胶治疗慢性难愈性创面的疗效分析[J].中国美容整形外科杂志,2021,32(12):741-744,755.
[44]
Barrionuevo DV, Laposy CB, Abegão KG, et al.Comparison of experimentally-induced wounds in rabbits treated with different sources of platelet-rich plasma[J].Lab Anim,2015,49(3):209-214.
[45]
Saputro ID, Rizaliyana S, Noverta DA.The effect of allogenic freeze-dried platelet-rich plasma in increasing the number of fibroblasts and neovascularization in wound healing[J].Ann Med Surg (Lond),2022,73:103217.
[46]
Chung TH, Baek DS, Kim N, et al.Topical allogeneic plateletrich plasma treatment for a massive cutaneous lesion induced by disseminated intravascular coagulation in a toy breed dog[J].Ir Vet J,2015,68(1):4.
[47]
左娜,王杨,刘刚,等.异体富血小板纤维蛋白治疗小儿小面积深度损伤创面[J].中国医科大学学报,2021,50(2):176-179.
[48]
胡以信, 袁杰,刘兵.异体血小板血浆凝胶治疗四肢烧伤残余创面的疗效分析[J].四川医学,2014,35(12):1587-1589.
[49]
Saris A, Pavenski K.Human leukocyte antigen alloimmunization and alloimmune platelet refractoriness[J].Transfus Med Rev,2020,34(4):250-257.
[50]
Curtis BR, McFarland JG.Human platelet antigens-2013[J].Vox Sang,2014,106(2):93-102.
[51]
Zhang ZY,Huang AW,Fan JJ,et al.The potential use of allogeneic platelet-rich plasma for large bone defect treatment: immunogenicity and defect healing efficacy[J].Cell Transplant, 2013,22(1):175-187.
[52]
姚丹, 赵帆,郝岱峰,等.异体富血小板血浆免疫原性的小型猪动物实验研究[J].中华损伤与修复杂志(电子版),2018,13(6):439-443.
[53]
黄红梅, 梁自文,施宗平,等.同种异体富血小板凝胶在难愈性皮肤溃疡中的临床疗效研究[J].第三军医大学学报,2017,39(19):1944-1948.
[54]
Schaller M,Hofmann A,Connor J,et al.Filtered platelet concentrates from pooled buffy coats show comparable storage lesions when stored for 9 d at 20-24 degrees C or when supplemented with thromboSol at 2-6 degrees C[J].Eur J Haematol,2000,64(6):401-410.
[55]
He M, Chen T, Lv Y, et al.The role of allogeneic platelet-rich plasma in patients with diabetic foot ulcer: current perspectives and future challenges[J].Front Bioeng Biotechnol,2022,10:993436.
[56]
Anitua E, Prado R, Orive G.Allogeneic platelet-rich plasma: at the dawn of an off-the-shelf therapy? [J].Trends Biotechnol,2017,5(2):91-93.
[57]
Scudellari M.Ageing research:blood to blood[J].Nature,2015,517(7535):426-429.
[1] 李煜, 王鹏, 陆翮, 冯蓉琴, 韩军涛. 采用低频脉冲电刺激治疗深Ⅱ度烧伤创面的临床观察[J]. 中华损伤与修复杂志(电子版), 2024, 19(06): 474-478.
[2] 赵芊, 李亚坤, 李智. 同种异体富血小板血浆临床应用的研究进展[J]. 中华损伤与修复杂志(电子版), 2024, 19(04): 364-367.
[3] 周清洁, 蒋萍萍, 梁云, 李琰. 脂质水胶体技术在创面愈合中的应用进展[J]. 中华损伤与修复杂志(电子版), 2024, 19(04): 360-363.
[4] 曹胜军, 李全, 符雪, 邵天喜, 周延华. 人脂肪间充质干细胞多层膜片对促进裸鼠皮肤缺损愈合的效果观察[J]. 中华损伤与修复杂志(电子版), 2024, 19(04): 341-347.
[5] 刘高雨, 罗鹏, 史春梦. 成纤维细胞重编程与创面修复的研究进展[J]. 中华损伤与修复杂志(电子版), 2024, 19(02): 176-179.
[6] 冯蓉琴, 王鹏, 李煜, 陆翮, 白晓智, 韩军涛. 抗菌肽在糖尿病创面愈合中作用的研究进展[J]. 中华损伤与修复杂志(电子版), 2024, 19(01): 78-82.
[7] 王鹏, 肖厚安, 贾赤宇. 不同因素调控巨噬细胞极化在慢性难愈性创面中的研究进展[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 454-459.
[8] 赵雅玫, 谢斌, 陈艳, 吴健. 抗生素骨水泥联合负压封闭引流对糖尿病足溃疡临床疗效的荟萃分析[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 427-433.
[9] 何雪锋, 赵世新, 李珮珊, 刘恒登, 谢举临. 卡奴卡叶提取物通过增强真皮成纤维细胞功能促进大鼠创面修复的效果观察[J]. 中华损伤与修复杂志(电子版), 2023, 18(05): 405-412.
[10] 贾蔓箐, 卞婧, 周业平. 对小剂量胰岛素局部注射促进脂肪干细胞移植成活及改善糖尿病创面愈合临床观察[J]. 中华损伤与修复杂志(电子版), 2023, 18(04): 312-316.
[11] 汪国建, 谭雨龙, 龙爽, 吕晓凡, 赵娜, 冉新泽, 王军平, 王涛. 高温高湿环境暴露对重度放创复合伤小鼠损伤恢复的影响[J]. 中华损伤与修复杂志(电子版), 2023, 18(04): 285-292.
[12] 程飚. 浓缩血小板制品在创面修复中应用与思考[J]. 中华损伤与修复杂志(电子版), 2023, 18(03): 276-276.
[13] 何泽亮, 李锦, 张程亮, 随振阳, 安亮恩, 刘玲玲, 姚媛媛, 张聚磊, 仇树林, 李晓东. 采用超声清创联合负压吸引疗法治疗深度烧伤溶痂创面的临床观察[J]. 中华损伤与修复杂志(电子版), 2023, 18(02): 123-127.
[14] 尚强强, 王凌峰, 巴特, 曹胜军, 周彪, 李全, 侯智慧, 闫增强, 陈强. 外泌型汗腺参与创面愈合的研究进展[J]. 中华损伤与修复杂志(电子版), 2022, 17(05): 450-453.
[15] 陈旭渊, 罗仕云, 李文忠, 李毅. 腺源性肛瘘经手术治疗后创面愈合困难的危险因素分析[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 82-85.
阅读次数
全文


摘要